ALSA Ventures (Group)

https://www.alsaventures.com

ALSA Holdings is a Europe based biotechnology investment firm with a focus on novel therapeutics at preclinical POC or early clinical development stage. The firm is managed by the founder and ex-CEO of Novotech, a leading midsize clinical CRO. The firm have considerable expertise and experience in clinical development and are an active investor. They have no geographic or therapeutic area constraints, and are equally open to seeding new companies, as investing in later syndicated rounds, or as a sole investor. *

	Start	2018-11-30 existent
	Industry	venture capital
	Industry 2	LIFE SCIENCES
	Person	Safarian, Alek (Alsa Holdings 201811 CEO)

	Region	London, Greater London
	Country	United Kingdom (GB)
	Street	78 Pall Mall
	City	SW1Y 5ES London
		Address record changed: 2023-02-23

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2024-09-10

Picture Kenes Exhibitions Biomed Israel 2025 Tel Aviv 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]